KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Short term Debt (2019 - 2025)

Historic Short term Debt for Biolife Solutions (BLFS) over the last 7 years, with Q3 2025 value amounting to $7.5 million.

  • Biolife Solutions' Short term Debt fell 3874.58% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 3874.58%. This contributed to the annual value of $10.9 million for FY2024, which is 7411.3% up from last year.
  • As of Q3 2025, Biolife Solutions' Short term Debt stood at $7.5 million, which was down 3874.58% from $10.1 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Short term Debt ranged from a high of $12.2 million in Q3 2024 and a low of $1.6 million during Q2 2022
  • In the last 5 years, Biolife Solutions' Short term Debt had a median value of $5.0 million in 2023 and averaged $5.8 million.
  • As far as peak fluctuations go, Biolife Solutions' Short term Debt crashed by 8647.2% in 2021, and later soared by 44852.71% in 2024.
  • Over the past 5 years, Biolife Solutions' Short term Debt (Quarter) stood at $5.1 million in 2021, then tumbled by 58.3% to $2.1 million in 2022, then surged by 193.97% to $6.3 million in 2023, then soared by 74.11% to $10.9 million in 2024, then plummeted by 31.54% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $10.1 million for Q2 2025, and $10.4 million during Q1 2025.